51³Ô¹ÏÍø

Congresswoman Pressley says Celgene put profit over people at House hearing

Massachusetts Representative Ayanna Pressley says at a House Oversight and Reform Committee hearing with pharmaceutical executives about drug pricing that multiple myeloma was a cancer compromised the immune system in place them at increased risk especially during the ongoing coronavirus pandemic, Revlimid could treat multiple myeloma but for no other reason than greed Celgene raised its price from $215 to $719, asking former Celgene CEO Mark Alles if he believed pharmaceutical companies should prioritize people over profit, Alles answering could only do well by doing good, had to take care of people to be successful the prioritize people medicines, Pressley interrupting to ask if people were put over profit, calling his answer in either yes or no so would take as a yes.
Massachusetts Representative Ayanna Pressley says at a House Oversight and Reform Committee hearing with pharmaceutical executives about drug pricing that multiple myeloma was a cancer compromised the immune system in place them at increased risk especially during the ongoing coronavirus pandemic, Revlimid could treat multiple myeloma but for no other reason than greed Celgene raised its price from $215 to $719, asking former Celgene CEO Mark Alles if he believed pharmaceutical companies should prioritize people over profit, Alles answering could only do well by doing good, had to take care of people to be successful the prioritize people medicines, Pressley interrupting to ask if people were put over profit, calling his answer in either yes or no so would take as a yes.
PURCHASE A LICENSE

Get personalized pricing by telling us when, where, and how you want to use this asset.

DETAILS

Restrictions:
May not be used as partisan political campaign material to promote or oppose the candidacy of any person for elective public office, and may not be used to distort the objects and purposes of the hearing, or cast discredit on or dishonor any member of the U.S. House of Representatives or U.S. Senate, or bring the House or Senate or any Member into disrepute.
Editorial #:
1278031762
Collection:
FedNet
Date created:
September 30, 2020
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:01:05:21
Location:
Washington, DC, United States
Mastered to:
QuickTime 8-bit H.264 HD 1280x720 30p
Source:
FedNet
Object name:
hov093020s